Showing results (371-380 of 609) with videos related to

Sort By:
Pageof 61
Urology|October 18, 2002
Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 menLori J Sokoll, Leslie A Mangold, Alan W Partin, et al.
Clinical Prostate Cancer|March 26, 2004
Comparison of total prostate-specific antigen and derivative levels in a screening population of black, white, and Korean-American menJae Park, Lori J Sokoll, Debra J Bruzek, et al.
BJU International|February 11, 2020
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillanceMufaddal K Mamawala, Alexa R Meyer, Patricia K Landis, et al.
Anticancer Research|May 17, 2019
Treatment of Metastatic Castration-resistant Prostate Cancer With Abiraterone and Enzalutamide Despite PSA ProgressionDaniel J Becker, Arjun D Iyengar, Salman R Punekar, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
Complications of initial prostate biopsy in a European randomized screening trialSuzanne van den Heuvel, Stacy Loeb, Xiaoye Zhu, et al.
European Urology|August 29, 2017
Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform DecisionsStacy Loeb, Qinlian Zhou, Uwe Siebert, et al.
The Journal of Urology|May 20, 2009
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen levelStacy Loeb, H Ballentine Carter, Patrick C Walsh, et al.
European Urology|June 22, 2013
Systematic review of complications of prostate biopsyStacy Loeb, Annelies Vellekoop, Hashim U Ahmed, et al.
BJU International|March 26, 2014
Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate-specific antigenVinay Prabhu, Ted Lee, Stacy Loeb, et al.
European Urology|January 21, 2014
Overdiagnosis and overtreatment of prostate cancerStacy Loeb, Marc A Bjurlin, Joseph Nicholson, et al.
Pageof 61